The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.

Researchers are studying a machine learning-powered warning system for breast cancer. It works by detecting subtle changes in a mammogram that humans can't spot, but could soon become cancer.

A deep learning (DL) model applied to standard screening mammograms substantially outperformed radiologist-assessed breast ...

The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...

Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with PI3K-targeted therapies. However, conventional molecular testing is not always ...

Pancreatic cancer remains one of the deadliest malignancies, due in large part to challenges with early diagnosis.  Advanced ...

Researchers at the University of South Florida have developed a comprehensive framework to test how accurately AI systems can ...

Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service (NHS) to use its artificial-intelligence-powered lung cancer diagnostic as part of an ...

A recent Perspective article published in the journal Cell argues that generative models could help address the complexity of cancer. The “Hallmarks of Cancer” provided a framework to systemize the ...